Warrant Exercise Proceeds definition

Warrant Exercise Proceeds means the aggregate amount that would be payable to the Company in respect of the outstanding Company Warrants, other than any Out-of-the-Money Warrants, immediately prior to the Effective Time if the holders thereof exercised such Company Options in full for cash as of the Effective Time.
Sample 1
Warrant Exercise Proceeds means an amount equal to the aggregate exercise price of all unexercised In-the-Money Warrants outstanding immediately prior to the Effective Time.
Sample 1
Warrant Exercise Proceeds means, in respect of the exercise of up to an aggregate of 1,250,000 warrants (whether on, before, or after the date hereof) pursuant to the Warrant Agreement, the amount of the cash proceeds received by Borrower in connection therewith.
Sample 1

Examples of Warrant Exercise Proceeds in a sentence

  • The Repurchase Amount is an amount equal to (i) $126,000,000 plus (ii) the Net Warrant Exercise Proceeds, provided that the Repurchase Amount shall not exceed $300,000,000 or be less than $0.

  • Pending the deployment of the Share Placement Net Proceeds and Warrant Exercise Proceeds (collectively, the “ Net Proceeds”), the Company intends to place the Share Placement Net Proceeds and Warrant Exercise Proceeds from the Proposed Placement and Warrants Issue with banks and/or financial institutions or use the Net Proceeds for any other purposes on a short- term basis, as the Directors may deem fit.

  • On December 15, 2021, Walmart consummated the gross exercise of vested warrant units for $173,795,651, and therefore, the Net Warrant Exercise Proceeds and the Repurchase Amount are currently $173,795,651 and approximately $300,000,000, respectively.

  • The formalism provides for interprocess synchronization each time an event occurs that is in their common alphabet.

  • The Company will make periodic announcements on the utilisation of the Share Placement Net Proceeds and Warrant Exercise Proceeds as and when the funds are materially disbursed and whether such use is in accordance with the stated use and in accordance with the percentage allocated.

  • Pending the deployment of the Share Placement Net Proceeds, the Consideration Net Proceeds and the Warrant Exercise Proceeds, such proceeds may be placed as deposits with banks and/or financial institutions and/or invested in short-term money markets or debt instruments or for any other purposes on a short-term basis as the Board may deem fit in the interest of the Group.

  • Where the Share Placement Net Proceeds and Warrant Exercise Proceeds are used for working capital purposes, the Company will provide a breakdown with specific details on how the Share Placement Net Proceeds and Warrant Exercise Proceeds have been applied in the announcements and the status report.

  • Where there is any material deviation from the stated use of the Share Placement Net Proceeds and Warrant Exercise Proceeds, the Company will announce the reasons for such deviation.

  • The Company will make periodic announcements on the utilisation of the Share Placement Net Proceeds, the Consideration Net Proceeds and the Warrant Exercise Proceeds as and when such proceeds are materially disbursed, and provide a status report on the use of the proceeds raised in its interim and full-year financial statements issued under Rule 705 of the Catalist Rules and its annual report.


More Definitions of Warrant Exercise Proceeds

Warrant Exercise Proceeds means the aggregate exercise proceeds received between the date of this Agreement and the Effective Time by CIC upon exercise of CIC Warrants, plus the aggregate exercise proceeds that would have been received by CIC upon exercise of any CIC Warrants that remain outstanding immediately prior to the Effective Time. The following terms not defined above are defined in the sections indicated below: Definition Defined Administrative Costs 2.9(d) Agreement Preamble Annual Financial Statements 4.4(a) Blue Sky Laws 3.2 Bank Holding Company Act 3.1 Bank Merger Recitals Bank Regulators 4.22 Board Recommendation 6.5(a) CBCA 2.1 CDB 2.1 Centennial Recitals Centennial Annual Financial Statements 4.4(b) Centennial Financial Statements 4.4(b) Change of Board Recommendation 6.5(a) CIC Preamble CIC Annual Financial Statements 4.4(a) CIC Class A Common Stock Recitals CIC Class B Common Stock Recitals CIC Employees 6.7(a) CIC Financial Statements 4.4(a) CIC Regulatory Reports 4.7 CIC Series A Preferred Stock 4.3 CIC Series B Preferred Stock Recitals CIC Series C Preferred Stock 4.3 Closing 2.8 Closing Date 2.8 Code Recitals Collection Expenses 2.9(d) Department 4.18(b) DGCL 2.1 Dissenting Shares 2.7(b) Dissenting Stockholders 2.7(a) Effective Date 2.2(d) Effective Time 2.2(d) Exchange Act 3.2 Expenses 8.3 FDIA 4.1(b) FDIC 3.2 Fractional Share Amount 2.3(b) FRB 2.1 Heartland Preamble Heartland Common Stock Recitals Heartland Plans 6.7(b) Heartland Regulatory Reports 3.7 Heartland Series D Preferred Stock Recitals Heartland 10-K Reports 3.5(a) Heartland 10-Q Report 3.5(a) Indemnified Party 6.10 Latest Balance Sheets 4.4(c) Latest Centennial Balance Sheet 4.4(b) Latest CIC Balance Sheet 4.4(a) Leased Real Property 4.12(c) Letter of Transmittal 2.6(a) Material Contracts 4.15(a) Merger Recitals Nasdaq 3.2 Net Scheduled Payment Per Class A Share 2.9(e) Operating Real Property 4.12(c) Owned Real Property 4.12(b) Prospectus/Proxy Statement 6.5(b) Real Property 4.12(c) Registration Statement 6.5(b) Regulatory Approvals 3.2 Related Centennial Statements 4.4(b) Related CIC Statements 4.4(a) Related Statements 4.4(c) Representatives 5.8(a) Required CIC Shareholder Vote 4.2 Required Consents 5.6 SEC 3.5(a) Securities Act 3.2 Shareholder Meeting 6.5(a) Securityholders’ Representative Preamble Servicing Fee 2.9(d) Summit Recitals Surviving Corporation 2.1 Title Objection 6.4(b) Work Permits 4.18(b)
Sample 1
Warrant Exercise Proceeds means the aggregate amount that would be payable to the Company in respect of the outstanding Company Warrants, other than any Out-of-the-Money Warrants, immediately prior to the Effective Time if the holders thereof exercised such Company Options in full for cash as of the Effective Time. Other capitalized terms used herein and not defined in this Exhibit A shall have the meanings assigned to such terms in the following Sections: “280G Stockholder Approval” 4.5 “Accounts Receivable” 2.4(d) “Accrued Vacation Liabilities” 4.7(a) “Acquirer” Preamble “Acquirer Benefit Plans” 4.7(b) “Acquirer Indemnified Person” 7.3(a) “Adjustment Calculations” 1.7(b) “Adjustment Notice” 1.7(b) “Agreement” Preamble “Agreement Date” Preamble “Basket” 7.4(a) “Board” Recitals “Bylaws” 5.3(a) “Certificate of Incorporation” 5.3(a) “Certificate of Merger” 1.1(d) “Certificates” 1.5(a) “Claim Certificate” 7.6(a) “Claims Period” 7.5 “Closing” 1.1(c) “Closing Date” 1.1(c) “COBRA” 2.13(c) “Commercially Reasonable Efforts” 1.6(e) “Company” Preamble “Company Authorizations” 2.8(b) “Company Disclosure Letter” ARTICLE II “Company Employee Plans” 2.13(a) “Company Financial Certificate” 1.7(a) “Company Fraud” 7.3(a)(vii) “Company Registered IP” 2.11(a) “Company Technology Sale” 1.6(a)(ii) “Company Technology Portion” 1.6(b) “Company Transfer Agent” 1.5(a) “Continuing Employee” 4.7(a) “Consenting Stockholders” Recitals “CTP Appraiser” 1.6(b) “CTP Notice” 1.6(b) “CTP Objection” 1.6(b) “Damages” 7.3(a) “Effective Time” 1.1(d) “Employment Agreement” Recitals “ERISA” 2.13(a) “ERISA Affiliate” 2.13(a) “Estimated Closing Cash” 1.7(a) “Estimated Closing Debt” 1.7(a) “Estimated Company Net Working Capital” 1.7(a) “Estimated Transaction Expenses” 1.7(a) “Export Approvals” 2.21 “Final Invoices” 5.3(b) “Final Merger Consideration” 1.7(f) “Final Net Working Capital Adjustment” 1.7(e) “Financial Statements” 2.4(a) “First Merger” Recitals “First Step Surviving Corporation” 1.1(a) “Fundamental Rep Claims” 7.4(a) “General Rep Claims” 7.4(a) “Indemnity Fund” 7.1(a) “Indemnity Release Date” 7.1(b) “Individual Fraud” 7.4(a) “Institution” 2.11(l) “IP Rep Claims” 7.4(b) “Joinder Agreement” Recitals “Key Employees” Recitals “Leased Real Property” 2.10(b)(ii) “Letter of Transmittal” 1.5(b) “Licensed IP” 2.11(a) “Lockup Agreement” Recitals “Mergers” Recitals “Merger Sub 1” Preamble “Merger Sub 2” Preamble “Merger Subs” Preamble “Milestone Payment” 1.6 “Non-Competition Agreement” Recitals “Notice of Objection” 1.7(c) “...
Sample 1
Warrant Exercise Proceeds means the aggregate amount of the exercise prices of all of the "in the money" Warrants (which amount, for the avoidance of doubt, is $1,250).
Sample 1

Related to Warrant Exercise Proceeds

  • Warrant Exercise Price means $0.01 per share.

  • Initial Exercise Price shall have the meaning set forth in Section 2.4.1.

  • Warrant Exercise Period shall commence (subject to Section 6(d) below), on the later of:

  • Exercise Price means the initial exercise price or the adjusted exercise price, depending on the context.

  • Option Exercise Price means the price at which a share of Common Stock may be purchased upon the exercise of an Option.

  • Aggregate Option Exercise Price means an amount equal to the aggregate dollar amount of the exercise price on all Company Options outstanding immediately prior to the Effective Time.

  • Initial Warrant Exercise Date means __________, 1997.

  • Total Exercise Price shall have the meaning set forth in Section 4(a) hereof.

  • SAR Exercise Price means the per share exercise price of a SAR granted to a Grantee under Section 9 hereof.

  • Current Warrant Price means, in respect of a share of Common Stock at any date herein specified, the price at which a share of Common Stock may be purchased pursuant to this Warrant on such date.

  • Cash Exercise with respect to Warrant Shares; and/or

  • Exercise Payment means the amount of money equal to the Exercise Price multiplied by the number of Optioned Shares specified in the Notice of Exercise;

  • Exercise Price Per Share ; hereinafter "Exercise Price" means the exercise price with respect to all Shares acquired pursuant to each exercise of the Option).

  • Warrant Price as used in this Agreement shall mean the price per share at which shares of Common Stock may be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days, provided, that the Company shall provide at least twenty (20) days prior written notice of such reduction to Registered Holders of the Warrants and, provided further that any such reduction shall be identical among all of the Warrants.

  • Aggregate Exercise Price means, in connection with the exercise of this Warrant at any time, an amount equal to the product obtained by multiplying (i) the Exercise Price times (ii) the number of shares of Common Stock for which this Warrant is being exercised at such time.

  • Warrant Share Number means at any time the aggregate number of shares of Warrant Stock which may at such time be purchased upon exercise of this Warrant, after giving effect to all prior adjustments and increases to such number made or required to be made under the terms hereof.

  • Purchase Option Price means the amount payable by a Lessee upon the exercise of its option to purchase a related 2024-1 Vehicle which amount equals (a) with respect to a Matured Vehicle, the Contract Residual Value plus any fees, taxes and other charges imposed in connection with such purchase and (b) with respect to a related 2024-1 Vehicle for which the related 2024-1 Lease has been terminated early by the Lessee, the sum of (i) any unpaid Monthly Payments due, (ii) any fees, taxes and other charges imposed in connection with the related 2024-1 Lease, (iii) an early termination fee and (iv) the Actuarial Payoff.

  • Option Price means the price at which a Share may be purchased by a Participant pursuant to an Option.

  • Warrant Value means the fair value of all warrants, options and other similar rights issued to a third party in connection with an Other Financing, determined by using a standard Black-Scholes option-pricing model using an expected volatility percentage as shall be mutually agreed by the Investor and the Company. In the case of a dispute relating to such expected volatility assumption, the Investor shall obtain applicable volatility data from three investment banking firms of nationally recognized reputation, and the parties hereto shall use the average thereof for purposes of determining the expected volatility percentage in connection with the Black-Scholes calculation referred to in the immediately preceding sentence. EXHIBIT A TO THE COMMON STOCK PURCHASE AGREEMENT FORM OF FIXED REQUEST NOTICE Reference is made to the Common Stock Purchase Agreement dated as of November 8, 2011, (the “Purchase Agreement”) between Arena Pharmaceuticals, a corporation organized and existing under the laws of the State of Delaware (the “Company”), and Azimuth Opportunity, L.P., an international limited partnership organized under the laws of the British Virgin Islands. Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Purchase Agreement. In accordance with and pursuant to Section 2.1 of the Purchase Agreement, the Company hereby issues this Fixed Request Notice to exercise a Fixed Request for the Fixed Amount Requested indicated below. Fixed Amount Requested: Optional Amount Dollar Amount: Pricing Period start date: Pricing Period end date: Settlement Date: Fixed Request Threshold Price: Optional Amount Threshold Price: Dollar Amount of Common Stock Currently Unissued under the Registration Statement; Dollar Amount of Common Stock Currently Available under the Aggregate Limit: Dated: By: Name Title: Address: Facsimile No. AGREED AND ACCEPTED By: Name Title: EXHIBIT B TO THE COMMON STOCK PURCHASE AGREEMENT FORM OF OPTIONAL AMOUNT NOTICE To: Fax#: Reference is made to the Common Stock Purchase Agreement dated as of November 8, 2011 (the “Purchase Agreement”) between Arena Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and Azimuth Opportunity, L.P., an international limited partnership organized under the laws of the British Virgin Islands (the “Investor”). Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Purchase Agreement. In accordance with and pursuant to Section 2.11 of the Purchase Agreement, the Investor hereby issues this Optional Amount Notice to exercise an Optional Amount for the Optional Amount Dollar Amount indicated below. Optional Amount Dollar Amount Exercised Number of Shares to be purchased VWAP on the date hereof: Discount Price: Settlement Date: Threshold Price: Dated: By: Name Title: Address: Facsimile No. EXHIBIT C TO THE COMMON STOCK PURCHASE AGREEMENT CERTIFICATE OF THE COMPANY CLOSING CERTIFICATE The undersigned, the [ ] of Arena Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), delivers this certificate in connection with the Common Stock Purchase Agreement, dated as of November 8, 2011 (the “Agreement”), by and between the Company and Azimuth Opportunity, L.P., an international limited partnership organized under the laws of the British Virgin Islands (the “Investor”), and hereby certifies on the date hereof that (capitalized terms used herein without definition have the meanings assigned to them in the Agreement):

  • Exercise Amount has the meaning set forth in Section 2(a).

  • Sponsor Exercise Fair Market Value means the average last reported sale price of the Ordinary Shares for the ten (10) trading days ending on the third (3rd) trading day prior to the date on which notice of exercise of the Private Placement Warrant is sent to the Warrant Agent;

  • New Exercise Date means a new Exercise Date if the Administrator shortens any Offering Period then in progress.

  • Conversion Right has the meaning set forth in Section 4.05(a) hereof.

  • Net Exercise means a Net Exercise as defined in Section 6.3(b)(iii).

  • Option Purchase Price has the meaning set forth in Section 9.36(b) hereof.

  • Common Warrant Shares means the shares of Common Stock issuable upon exercise of the Common Warrants.